ArticleFrontiers in public health2025
Knowledge, attitudes, and practices toward biologics among systemic lupus erythematosus patients: a cross-sectional study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Changes in attitudes toward systemic lupus erythematosus and associated factors: a retrospective cross-sectional study from China.Frontiers in immunology · 2026Observational
- Factors Influencing Acceptance of Biologics and Small Molecule Targeted Drugs Among Patients with Chronic Spontaneous Urticaria: A Cross-Sectional Study.Patient preference and adherence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the knowledge, attitudes, and practices (KAP) toward biologics among systemic lupus erythematosus (SLE) patients. Methods: A cross-sectional study was conducted at Nanjing Drum Tower Hospital from March 2023 to January 2024. Demographic information and KAP were obtained through the distribution of self-designed questionnaires. Results: A total of 543 SLE patients participated in this study, with a mean age of 39.14 ± 13.08 years. The mean scores for knowledge, attitude, and practice were 6.08 ± 5.49 (possible range: 0-32), 33.14 ± 4.01 (possible range: 10-50), and 12.06 ± 3.95 (possible range: 6-30), respectively. Multivariate logistic regression analysis revealed that knowledge score (OR = 1.08, 95% CI: 1.019-1.144, Conclusion: SLE patients demonstrated inadequate knowledge, suboptimal attitudes, and passive practices regarding biologics. It is recommended that healthcare providers prioritize education and interventions aimed at enhancing knowledge, fostering positive attitudes, and promoting proactive practices regarding biologic therapies among SLE patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.